A clinical study determining MMP2, MMP9, and MMP10 levels in cerebrospinal fluid (CSF) and plasma in 52 AD patients, 26 matched controls, and 24 vascular dementia patients led Duits et al. [22] to implicate the involvement of MMP2 and MMP10 in AD pathology. Here, MMP10 is linked to Alzheimer disease.